Newly approved COVID-19 antibody drug has Tri-State connection

Local

EVANSVILLE, Ind. (WEHT) – U.S. health officials have allowed emergency use of the first antibody drug to help the immune system fight COVID-19.

The Food and Drug Administration on Monday cleared the experimental drug from Eli Lilly for people 12 and older with mild or moderate COVID-19 not requiring hospitalization.

Eyewitness News Brandon Bartlett talked to a local doctor that was a part of the process.

For the latest breaking news and stories from across the
Tri-State, follow Eyewitness News on Facebook and Twitter.

(This story was originally published on November 10, 2020)

Copyright 2021 Nexstar Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Trending Stories